Cargando…

Identification of an IL-22-Dependent Gene Signature as a Pharmacodynamic Biomarker

Interleukin-22 (IL-22) plays a role in epithelial barrier function and repair, and may provide benefits in conditions like inflammatory bowel disease. However, limited human data are available to assess the clinical effect of IL-22 administration. This study used a human intestinal cell line to iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rae, Julie, Hackney, Jason, Huang, Kevin, Keir, Mary, Herman, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347589/ https://www.ncbi.nlm.nih.gov/pubmed/34360971 http://dx.doi.org/10.3390/ijms22158205

Ejemplares similares

The role of IL-22 in intestinal health and disease
por: Keir, Mary E., et al.
Publicado: (2020)

IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice
por: Kolumam, Ganesh, et al.
Publicado: (2017)

Phosphatidylcholine Metabolic Transformation and Progression Signature as a Pharmacodynamic Biomarker
por: Aboagye, Eric O.
Publicado: (2010)

Microbiota-Dependent Effects of IL-22
por: Sabihi, Morsal, et al.
Publicado: (2020)

The development of colitis in Il10(−/−) mice is dependent on IL-22
por: Gunasekera, Dilini C., et al.
Publicado: (2020)

Decidual Interleukin-22-Producing CD4+ T Cells (Th17/Th0/IL-22+ and Th17/Th2/IL-22+, Th2/IL-22+, Th0/IL-22+), Which Also Produce IL-4, Are Involved in the Success of Pregnancy
por: Logiodice, Federica, et al.
Publicado: (2019)

IL-22 Binding Protein (IL-22BP) in the Regulation of IL-22 Biology
por: Zenewicz, Lauren A.
Publicado: (2021)

A blood-based 22-gene expression signature for hepatocellular carcinoma identification
por: Zheng, Jie, et al.
Publicado: (2020)

Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson
por: Hatz, Sonja, et al.
Publicado: (2019)

Identification of genetic variants of the IL‐22 gene in association with an altered risk of COPD susceptibility
por: Wang, Yan, et al.
Publicado: (2022)

Association of IL-22 and IL-22RA1 gene variants in Iranian patients with colorectal cancer
por: Mohebbi, Seyed Reza, et al.
Publicado: (2021)

Identification of an age-dependent biomarker signature in children and adolescents with autism spectrum disorders
por: Ramsey, Jordan M, et al.
Publicado: (2013)

Pharmacodynamic Modelling of Biomarker Data in Oncology
por: Jackson, Robert C.
Publicado: (2012)

The interaction between prognostic and pharmacodynamic biomarkers
por: Bouranis, L, et al.
Publicado: (2013)

Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression
por: Ryffel, Bernhard, et al.
Publicado: (2019)

NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition
por: Madan, Babita, et al.
Publicado: (2016)

IL-22 gene transfer in collagen-induced arthritis
por: Apparailly, F, et al.
Publicado: (2004)

IL-22 alters gut microbiota composition and function to increase aryl hydrocarbon receptor activity in mice and humans
por: Mar, Jordan S., et al.
Publicado: (2023)

Corrigendum: Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression
por: Ryffel, Bernhard, et al.
Publicado: (2020)

Targeting IL-22 and IL-22R protects against experimental osteoarthritis
por: Yi, Changhua, et al.
Publicado: (2020)

IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence
por: Chiang, Hung-Yu, et al.
Publicado: (2022)

Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
por: Kelly, Kaela, et al.
Publicado: (2020)

IL-21 induces IL-22 production in CD4+ T-cells
por: Yeste, Ada, et al.
Publicado: (2014)

Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids
por: Hu, Yanhua, et al.
Publicado: (2018)

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
por: Cai, Jialin, et al.
Publicado: (2017)

Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion
por: Fallon, Padraic G., et al.
Publicado: (2006)

IL-22 dampens the T cell response in experimental malaria
por: Sellau, Julie, et al.
Publicado: (2016)

IL22/IL-22R Pathway Induces Cell Survival in Human Glioblastoma Cells
por: Akil, Hussein, et al.
Publicado: (2015)

Characterization of IL-22 Bioactivity and IL-22-Positive Cells in Grass Carp Ctenopharyngodon idella
por: Yang, Yibin, et al.
Publicado: (2020)

Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus mykiss
por: Hu, Yehfang, et al.
Publicado: (2019)

A Critical Role of the IL-22–IL-22 Binding Protein Axis in Hepatocellular Carcinoma
por: Giannou, Anastasios D., et al.
Publicado: (2022)

Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children
por: Hathout, Yetrib, et al.
Publicado: (2016)

Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval
por: Strauss, David G., et al.
Publicado: (2022)

Delivery of interleukin-22 binding protein (IL-22BP) gene by cationic micelle for colon cancer gene therapy
por: Men, Ke, et al.
Publicado: (2018)

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma
por: Qi, Ying, et al.
Publicado: (2022)

Multiple signatures of a disease in potential biomarker space: Getting the signatures consensus and identification of novel biomarkers
por: Ow, Ghim Siong, et al.
Publicado: (2015)

Development and application of a biomarker assay for determining the pharmacodynamic activity of an antagonist candidate biotherapeutic antibody to IL21R in whole blood
por: Arai, Maya, et al.
Publicado: (2010)

The good and the bad about separation anxiety: roles of IL-22 and IL-22BP in liver pathologies
por: Lücke, Jöran, et al.
Publicado: (2021)

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib
por: Pommier, A J C, et al.
Publicado: (2014)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
por: Xu, Lixia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91spaoj8fg1b1mduascf547squ